Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Tallman
    Tallman
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (293)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (15)
  5. Review (11)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (293)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (14)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (350)
  2. Haematologica Meeting Reports (4)

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone disease in monoclonal gammopathy of undetermined significance: Results from a screened population-based study
    Meeting Abstract

    Thorsteinsdottir, S.; Lund, S. H.; Lindqvist, E.; Sigurdsson, G.; Costello, R.; Burton, D.; Steingrimsdottir, H.; Launer, L. J.; Gudnason, V.; Eiriksdottir, G.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Impact of family history on risk of progression of MGUS to multiple myeloma: A population-based study
    Meeting Abstract

    Aradottir, K.; Lund, S. H.; Landgren, O.; Bjorkholm, M.; Turesson, I.; Kristinsson, S. Y.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Dietary habits across the lifespan and risk of monoclonal gammopathy of undetermined significance: A population based screening study
    Meeting Abstract

    Thordardottir, M.; Lindqvist, E.; Lund, S.; Costello, R.; Torfadottir, J.; Burton, D.; Steingrimsdottir, L.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Diagnosis, prognosis and risk assessment of multiple myeloma: Identifying gaps and addressing education needs for hematologists and oncologists
    Meeting Abstract

    Van Laar, E.; Fagerlie, S.; Landgren, O.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Patterns of idelalisib treatment-emergent lymphocytosis in patients with CLL or SLL
    Meeting Abstract

    Ghia, P.; Cheson, B. D.; Furman, R. R.; Hallek, M.; Hillmen, P.; O'Brien, S. M.; Sharman, J. P.; Dubowy, R. L.; Velasco, B.; Waldapfel, C. C.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Phase 1 final results and phase 2a dose selection for cerdulatinib (Prt062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P.; Flinn, I.; Wagner-Johnston, N.; Burger, J.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G.; Leeds, J.; Sabalvaro-Torres, A.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Comparison of pace clinical trial vs real-world ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Preliminary findings from a chart review of lower dosing of ponatinib in chronic myeloid leukemia (CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L.; Inguilizian, A.; du Moulin, R.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Phase 1b study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma: Keynote-013
    Meeting Abstract

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Thompson, S.; Marinello, P.; Chlosta, S.; Shipp, M. A.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia
    Meeting Abstract

    Kühn, M. W.; Song, E.; Feng, Z.; Sinha, A.; Chen, C. W.; Deshpande, A. J.; Cusan, M.; Farnoud, N. R.; Koche, R.; Bradner, J. E.; more...
    Haematologica (2016)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: